Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Carrier

Showing results (311-320 of 421) with videos related to

Pageof 43
Sort By:
Plos One|June 22, 2026
The association between patient preferred language and end-of-life outcomes of home care patients who died from a cancer in Ontario, Canada - A retrospective cohort studyTzu-Fei Wang, Lise M Bjerre, Maya Gibb, et al.
Annals of Surgery|August 13, 2021
Efficacy and Safety of Low Molecular Weight Heparin Versus Unfractionated Heparin for Prevention of Venous Thromboembolism in Trauma Patients: A Systematic Review and Meta-analysisAlexandre Tran, Shannon M Fernando, Marc Carrier, et al.
AMIA ... Annual Symposium Proceedings. AMIA Symposium|March 21, 2022
Towards a framework for comparing functionalities of multimorbidity clinical decision support: A literature-based feature set and benchmark casesDympna O'Sullivan, William Van Woensel, Szymon Wilk, et al.
Critical Care Medicine|March 11, 2026
Anti-Xa Levels With Venous Thromboembolism Prophylaxis in Critical Care: A Systematic Review and Meta-AnalysisKevin M Durr, Alexa Ehlebracht, Bram Rochwerg, et al.
Circulation|June 9, 2012
Development of a clinical prediction rule for risk stratification of recurrent venous thromboembolism in patients with cancer-associated venous thromboembolismMartha L Louzada, Marc Carrier, Alejandro Lazo-Langner, et al.
Pharmacological Reviews|May 8, 2026
Thrombin generation and the pharmacodynamics of parenteral anticoagulantsJoseph R Shaw, Cheryl L Maier, Michaël Hardy, et al.
Critical Care Medicine|March 25, 2020
Impact of Anticoagulation on Mortality and Resource Utilization Among Critically Ill Patients With Major BleedingShannon M Fernando, Garrick Mok, Lana A Castellucci, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|October 9, 2025
Indefinite anticoagulation with reduced-intensity direct oral anticoagulants in patients with splanchnic vein thrombosis. An international practice surveyAurélien Delluc, Marc Carrier, Mandy Lauw, et al.
American Journal of Hematology|June 7, 2021
Impact of anticoagulation on recurrent thrombosis and bleeding after hematopoietic cell transplantationKylee L Martens, Christopher I Amos, Cristhiam Rojas Hernandez, et al.
CJC Open|April 7, 2022
Amiodarone, Verapamil, or Diltiazem Use With Direct Oral Anticoagulants and the Risk of Hemorrhage in Older AdultsKevin Hill, Ewa Sucha, Emily Rhodes, et al.
Pageof 43

Showing results (311-320 of 421) with videos related to

Sort By:
Pageof 43
Plos One|June 22, 2026
The association between patient preferred language and end-of-life outcomes of home care patients who died from a cancer in Ontario, Canada - A retrospective cohort studyTzu-Fei Wang, Lise M Bjerre, Maya Gibb, et al.
Annals of Surgery|August 13, 2021
Efficacy and Safety of Low Molecular Weight Heparin Versus Unfractionated Heparin for Prevention of Venous Thromboembolism in Trauma Patients: A Systematic Review and Meta-analysisAlexandre Tran, Shannon M Fernando, Marc Carrier, et al.
AMIA ... Annual Symposium Proceedings. AMIA Symposium|March 21, 2022
Towards a framework for comparing functionalities of multimorbidity clinical decision support: A literature-based feature set and benchmark casesDympna O'Sullivan, William Van Woensel, Szymon Wilk, et al.
Critical Care Medicine|March 11, 2026
Anti-Xa Levels With Venous Thromboembolism Prophylaxis in Critical Care: A Systematic Review and Meta-AnalysisKevin M Durr, Alexa Ehlebracht, Bram Rochwerg, et al.
Circulation|June 9, 2012
Development of a clinical prediction rule for risk stratification of recurrent venous thromboembolism in patients with cancer-associated venous thromboembolismMartha L Louzada, Marc Carrier, Alejandro Lazo-Langner, et al.
Pharmacological Reviews|May 8, 2026
Thrombin generation and the pharmacodynamics of parenteral anticoagulantsJoseph R Shaw, Cheryl L Maier, Michaël Hardy, et al.
Critical Care Medicine|March 25, 2020
Impact of Anticoagulation on Mortality and Resource Utilization Among Critically Ill Patients With Major BleedingShannon M Fernando, Garrick Mok, Lana A Castellucci, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|October 9, 2025
Indefinite anticoagulation with reduced-intensity direct oral anticoagulants in patients with splanchnic vein thrombosis. An international practice surveyAurélien Delluc, Marc Carrier, Mandy Lauw, et al.
American Journal of Hematology|June 7, 2021
Impact of anticoagulation on recurrent thrombosis and bleeding after hematopoietic cell transplantationKylee L Martens, Christopher I Amos, Cristhiam Rojas Hernandez, et al.
CJC Open|April 7, 2022
Amiodarone, Verapamil, or Diltiazem Use With Direct Oral Anticoagulants and the Risk of Hemorrhage in Older AdultsKevin Hill, Ewa Sucha, Emily Rhodes, et al.
Pageof 43